This is not how pharma companies make money. The big earners are lifestyle drugs under patent that can be flogged to a lot of people. New patented painkillers for arthritis, viagra and Ozempic are where it’s at. If they want to make money off troons, it would be through finding a currently patented anti-depressant or anti-anxiety pill treated dysphoria coincidentally. They could then extend the patent. Hormones are not under patent.
Not sure I buy this. The original class action doesn’t go away, and now the company is creating a new class of plaintiffs for a future suit. Lupron et al have a wider pool of potential users than unhappy children: the great demographic bulge of baby boomer men with prostrate cancer. After that, sure, future users would be an issue, but the patent eventually ends and it just becomes another low profit item in the inventory.
The real moneymakers in all of this are the surgeons and hospitals, because getting more people to buy surgery of any type is how they make their money. Who sets up gender clinics to funnel work their way? They do.